1Department of Microbiology & Immunology, Walther Oncology Center, Indiana University School of Medicine, Indianapolis 46202-512, USA. asrivast@iupui.edu
Parvovirus vectors show promise as safe alternatives for gene therapy, proving effective in clinical trials for cystic fibrosis and hemophilia B. Their unique features suggest broad potential for treating various human diseases.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: